DEM Bio
- Headquarters
- Boston, Massachusetts
- Website
- dembiopharma.com
- Total Funding
- $95.0M
About
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting 'Don't eat me' (DEM) and 'Eat me' (EM) signals on cancer cells and macrophages.
Funding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account